JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basu, T. K.
Right arrow Articles by Temple, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basu, T. K.
Right arrow Articles by Temple, N.

Journal of the American College of Nutrition, Vol 8, Issue 6 524-529, Copyright © 1989 by American College of Nutrition


JOURNAL ARTICLE

Serum vitamins A and E, beta-carotene, and selenium in patients with breast cancer

T. K. Basu, G. B. Hill, D. Ng, E. Abdi and N. Temple
Department of Foods and Nutrition, Cross Cancer Institute, Slowpoke Facility, University of Alberta, Edmonton, Canada.

A total of 89 subjects including 30 breast cancer patients with distal metastases, 29 patients with benign breast disease, and 30 healthy subjects were studied. Serum samples from these subjects were obtained from the National Cancer Institute (NCI) Breast Cancer Serum Bank, Bethesda. Serum concentrations of vitamin A and its transport proteins (prealbumin and retinol-binding protein [RBP]), beta-carotene, vitamin E, and selenium were determined. For each of these parameters the mean for the breast cancer patients was lower than that of the healthy subjects. The differences between healthy subjects and patients with either breast cancer or benign breast disease were, however, statistically significant only in the case of RBP (p less than 0.05). In the case of vitamin A and its transport proteins these differences were reduced by comparing the cancer patients with the benign breast disease patients rather than with the healthy controls. This indicates that the low serum levels for those three parameters may be merely a consequence of disease in general rather than a feature of cancer per se.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Cui, S. Vogt, N. Olson, A. G. Glass, and T. E. Rohan
Levels of Zinc, Selenium, Calcium, and Iron in Benign Breast Tissue and Risk of Subsequent Breast Cancer
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1682 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark
Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial
Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. E. Rohan
Invited Commentary: Serum Carotenoids and Breast Cancer
Am. J. Epidemiol., June 15, 2001; 153(12): 1148 - 1150.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American College of Nutrition.